In conclusion, our mass cytometry-guided transcriptomic analysis of BM CD8+ T cells at the single-cell level reveals distinct abnormalities linked to AZA response in patients with AML and MDS. The gene discussed is CD8A; the disease is myelodysplastic syndrome.